▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #4174 by analyst upside · 2026-08-14
MRNA
Moderna, Inc.
Healthcare · Market Cap $25B · P/E 0x
ANALYST PRICE TARGET
-20.1%
implied upside to consensus target
Current Price $63.65
Consensus Target $50.84
Bull Target $79.0
Bear Target $25.0
Analysts Covering 19
ANALYST CONSENSUS - HOLD
Strong Buy
2
Buy
2
Hold
13
Sell
2
52-Week Low $22.28
52-Week High $85.6
YTD Return +106.3%
FUNDAMENTALS
Market Cap $25B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-7.98
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $2.2B
Profit Margin -141.4%
52-WEEK RANGE
52-Week Low $22.28
52-Week High $85.6
Current Price $63.65
Bear Target $25.0
Bull Target $79.0
● Now $63.65 ● Target $50.84
TRADING DATA
Avg Volume 6.9M
YTD Return +106.3%
Analyst Count 19
Consensus Hold
Upside to Target -20.1%
Last Updated 2026-08-14

ANALYST SUMMARY

Moderna, Inc. (MRNA) is currently trading at $63.65 with a Wall Street consensus price target of $50.84, which is 20.1% below the current price over the next 12 months. 19 analysts currently cover MRNA, with a consensus rating of Hold - 21% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $79.0, while the most cautious has a target of $25.0.

MRNA operates in the Healthcare sector with a market capitalisation of $25B. The stock is up 106.3% year-to-date and is currently trading near the upper end of its 52-week range of $22.28 – $85.6.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

INCY +3.9%
Incyte Corporation
$24B · P/E 15.4x · Buy
THC +5.6%
Tenet Healthcare Corporation
$22B · P/E 10.3x · Buy
DGX +4.2%
Quest Diagnostics Incorporated
$26B · P/E 25.1x · Buy
LH +4.7%
Labcorp Holdings Inc.
$26B · P/E 26.7x · Buy
PHG +17.6%
Koninklijke Philips N.V.
$27B · P/E 20.7x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for MRNA, with each firm's 90-day track record across all stocks we track. See full firm rankings →

B of A Securities - Reiterated
Underperform → Underperform 2026-06-08 Building track record
UBS - Reiterated
Neutral → Neutral 2026-05-04 33% win rate (6 calls)
Goldman Sachs - Reiterated
Neutral → Neutral 2026-05-04 Building track record
Evercore ISI Group - Reiterated
In-Line → In-Line 2026-05-04 Building track record
RBC Capital - Reiterated
Sector Perform → Sector Perform 2026-05-04 Building track record
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-04-02 Building track record
Piper Sandler - Reiterated
Overweight → Overweight 2026-02-23 14% win rate (7 calls)
Goldman Sachs - Reiterated
Neutral → Neutral 2026-02-17 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
38
out of 100
Coverage depth
23/30
Consensus clarity
13/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →